Literature DB >> 25825759

Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.

Benhur Lee1, Olivier Pernet2, Asim A Ahmed3, Antra Zeltina4, Shannon M Beaty5, Thomas A Bowden6.   

Abstract

The discovery of African henipaviruses (HNVs) related to pathogenic Hendra virus (HeV) and Nipah virus (NiV) from Southeast Asia and Australia presents an open-ended health risk. Cell receptor use by emerging African HNVs at the stage of host-cell entry is a key parameter when considering the potential for spillover and infection of human populations. The attachment glycoprotein from a Ghanaian bat isolate (GhV-G) exhibits <30% sequence identity with Asiatic NiV-G/HeV-G. Here, through functional and structural analysis of GhV-G, we show how this African HNV targets the same human cell-surface receptor (ephrinB2) as the Asiatic HNVs. We first characterized this virus-receptor interaction crystallographically. Compared with extant HNV-G-ephrinB2 structures, there was significant structural variation in the six-bladed β-propeller scaffold of the GhV-G receptor-binding domain, but not the Greek key fold of the bound ephrinB2. Analysis revealed a surprisingly conserved mode of ephrinB2 interaction that reflects an ongoing evolutionary constraint among geographically distal and phylogenetically divergent HNVs to maintain the functionality of ephrinB2 recognition during virus-host entry. Interestingly, unlike NiV-G/HeV-G, we could not detect binding of GhV-G to ephrinB3. Comparative structure-function analysis further revealed several distinguishing features of HNV-G function: a secondary ephrinB2 interaction site that contributes to more efficient ephrinB2-mediated entry in NiV-G relative to GhV-G and cognate residues at the very C terminus of GhV-G (absent in Asiatic HNV-Gs) that are vital for efficient receptor-induced fusion, but not receptor binding per se. These data provide molecular-level details for evaluating the likelihood of African HNVs to spill over into human populations.

Entities:  

Keywords:  emerging virus; glycoprotein; henipavirus; structure; viral attachment

Mesh:

Substances:

Year:  2015        PMID: 25825759      PMCID: PMC4418902          DOI: 10.1073/pnas.1501690112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein.

Authors:  G D Parks; R A Lamb
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  Evil versus 'eph-ective' use of ephrin-B2.

Authors:  Benhur Lee; Zeynep Akyol Ataman; Lei Jin
Journal:  Nat Struct Mol Biol       Date:  2008-06       Impact factor: 15.369

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

Review 4.  What does structure tell us about virus evolution?

Authors:  Dennis H Bamford; Jonathan M Grimes; David I Stuart
Journal:  Curr Opin Struct Biol       Date:  2005-11-03       Impact factor: 6.809

5.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.

Authors:  Ping Yuan; Thomas B Thompson; Beth A Wurzburg; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Structure       Date:  2005-05       Impact factor: 5.006

6.  Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.

Authors:  Nicolas Sabarth; M Keith Howard; Helga Savidis-Dacho; André van Maurik; P Noel Barrett; Otfried Kistner
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.

Authors:  Thomas A Bowden; A Radu Aricescu; Robert J C Gilbert; Jonathan M Grimes; E Yvonne Jones; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2008-05-18       Impact factor: 15.369

8.  Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain.

Authors:  Brett D Welch; Ping Yuan; Sayantan Bose; Christopher A Kors; Robert A Lamb; Theodore S Jardetzky
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

9.  The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus?

Authors:  Andrew C Breed; Joanne Meers; Indrawati Sendow; Katharine N Bossart; Jennifer A Barr; Ina Smith; Supaporn Wacharapluesadee; Linfa Wang; Hume E Field
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  26 in total

Review 1.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

2.  Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely Virus, from Fruit Bats in Madagascar.

Authors:  Sharline Madera; Amy Kistler; Hafaliana C Ranaivoson; Vida Ahyong; Angelo Andrianiaina; Santino Andry; Vololoniaina Raharinosy; Tsiry H Randriambolamanantsoa; Ny Anjara Fifi Ravelomanantsoa; Cristina M Tato; Joseph L DeRisi; Hector C Aguilar; Vincent Lacoste; Philippe Dussart; Jean-Michel Heraud; Cara E Brook
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

Review 3.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

Review 4.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

5.  Cross-strand disulfides in the hydrogen bonding site of antiparallel β-sheet (aCSDhs): Forbidden disulfides that are highly strained, easily broken.

Authors:  Naomi L Haworth; Michael J Wouters; Morgan O Hunter; Lixia Ma; Merridee A Wouters
Journal:  Protein Sci       Date:  2019-01       Impact factor: 6.725

6.  Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.

Authors:  Steinar Halldorsson; Anna-Janina Behrens; Karl Harlos; Juha T Huiskonen; Richard M Elliott; Max Crispin; Benjamin Brennan; Thomas A Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

7.  Novel Roles of the Nipah Virus Attachment Glycoprotein and Its Mobility in Early and Late Membrane Fusion Steps.

Authors:  Victoria Ortega; J Lizbeth Reyes Zamora; I Abrrey Monreal; Daniel T Hoffman; Shahrzad Ezzatpour; Gunner P Johnston; Erik M Contreras; Fernando J Vilchez-Delgado; Hector C Aguilar
Journal:  mBio       Date:  2022-05-04       Impact factor: 7.786

8.  Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo.

Authors:  Viktoriya Borisevich; Benhur Lee; Andrew Hickey; Blair DeBuysscher; Christopher C Broder; Heinz Feldmann; Barry Rockx
Journal:  J Infect Dis       Date:  2015-09-10       Impact factor: 5.226

9.  Emerging Paramyxoviruses: Receptor Tropism and Zoonotic Potential.

Authors:  Antra Zeltina; Thomas A Bowden; Benhur Lee
Journal:  PLoS Pathog       Date:  2016-02-25       Impact factor: 6.823

10.  Nipah Virus C Protein Recruits Tsg101 to Promote the Efficient Release of Virus in an ESCRT-Dependent Pathway.

Authors:  Arnold Park; Tatyana Yun; Frederic Vigant; Olivier Pernet; Sohui T Won; Brian E Dawes; Wojciech Bartkowski; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2016-05-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.